Holen Sie sich die Stockscreener-App
103.25
0.74%
-0.7933
Schlusskurs vom Vortag:
$104.04
Offen:
$103.64
24-Stunden-Volumen:
649.89K
Relative Volume:
0.60
Marktkapitalisierung:
$4.78B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-63.78M
KGV:
-38.52
EPS:
-2.68
Netto-Cashflow:
$-53.91M
1W Leistung:
+5.92%
1M Leistung:
+38.58%
6M Leistung:
+699.92%
1J Leistung:
+705.54%
1-Tages-Spanne:
$102.34
$107.70
1-Wochen-Bereich:
$97.50
$108.91
52-Wochen-Spanne:
$7.575
$108.91
Celcuity Inc Stock (CELC) Company Profile
Firmenname
Celcuity Inc
Sektor
Branche
Telefon
763-392-0767
Adresse
16305 36TH AVENUE N, MINNEAPOLIS, MN
Vergleichen Sie CELC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CELC
Celcuity Inc
|
103.27 | 4.81B | 0 | -63.78M | -53.91M | -2.68 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.06 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
699.32 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
417.57 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
891.91 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.93 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Celcuity Inc Stock (CELC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Eingeleitet | Wolfe Research | Outperform |
| 2025-11-17 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-09-22 | Eingeleitet | Guggenheim | Buy |
| 2025-07-01 | Fortgesetzt | Stifel | Buy |
| 2024-07-22 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-22 | Eingeleitet | Stifel | Buy |
| 2023-12-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-09-07 | Eingeleitet | Jefferies | Buy |
| 2021-07-29 | Eingeleitet | Cowen | Outperform |
| 2021-07-27 | Eingeleitet | Needham | Buy |
| 2021-01-28 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-11 | Fortgesetzt | Craig Hallum | Buy |
| 2018-11-20 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Celcuity Inc Aktie (CELC) Neueste Nachrichten
New Highs: How interest rate cuts could boost Celcuity Inc stockWeekly Trade Summary & Safe Entry Zone Identification - BỘ NỘI VỤ
Dir Furcht Acquires 250 Of Celcuity Inc [CELC] - TradingView
Earnings Update: Why Celcuity Inc. stock is trending among retail tradersJuly 2025 Breakouts & Safe Entry Trade Signal Reports - BỘ NỘI VỤ
(CELC) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Celcuity stock rallies on Phase III breast cancer trial progress - MSN
17,848 Shares in Celcuity, Inc. $CELC Purchased by M Holdings Securities Inc. - MarketBeat
Celcuity, Inc. (NASDAQ:CELC) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Celcuity (CELC) Price Target Increased by 11.17% to 108.57 - Nasdaq
Dir Buller Files To Sell 3,000 Of Celcuity Inc [CELC] - TradingView
Celcuity (NASDAQ:CELC) Sets New 1-Year HighShould You Buy? - MarketBeat
Saturn V Capital Management LP Boosts Stock Position in Celcuity, Inc. $CELC - MarketBeat
Geode Capital Management LLC Sells 42,691 Shares of Celcuity, Inc. $CELC - MarketBeat
Could Celcuity Drain The Lifeline Of Tumor Growth With Gedatolisib's Comprehensive Approach? - RTTNews
Aug Reactions: Why Celcuity Inc stock is rated strong buyPortfolio Value Summary & Free Accurate Trade Setup Notifications - BỘ NỘI VỤ
Celcuity stock hits all-time high at 103.23 USD By Investing.com - Investing.com Canada
Celcuity Stock Near All-Time Highs — And This Major Biotech Investor Is Still Jumping In - AOL.com
Is Celcuity Inc. stock a defensive play in 2025Weekly Trend Summary & Stock Portfolio Risk Management - Newser
3 Stocks You’ll Wish You Bought Before 2026 - Investing.com
Celcuity Director Cashes In on Stock Sale! - TipRanks
Celcuity (NASDAQ:CELC) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says - MarketBeat
Aug Swings: Does Celcuity Inc stock trade at a discount to peersWeekly Stock Summary & Long-Term Investment Growth Plans - BỘ NỘI VỤ
Jefferies Maintains Celcuity (CELC) Buy Recommendation - MSN
Celcuity submits gedatolisib new drug application to the FDA - MSN
Is Celcuity Inc. stock a bargain at current levelsEarnings Growth Report & Real-Time Chart Breakout Alerts - Newser
Jefferies raises Celcuity stock price target to $134 on positive trial outlook By Investing.com - Investing.com South Africa
Jefferies raises Celcuity stock price target to $134 on positive trial outlook - Investing.com
Dir Buller Files To Sell 1,100 Of Celcuity Inc [CELC] - TradingView
Is Celcuity Inc a good long term investmentChart Pattern Recognition & Small Budget Capital Growth - earlytimes.in
How to Value Roto Pumps Limited Stock Using DCF AnalysisTechnical Resistance Breaks & Rapid Capital Growth - earlytimes.in
Virtus Investment Advisers LLC Has $100,000 Stock Position in Celcuity, Inc. $CELC - MarketBeat
Celcuity outlines $2.5B–$3B peak revenue potential for gedatolisib amid accelerated launch preparations - MSN
How FDA Real-Time Review for Gedatolisib Has Changed Celcuity’s (CELC) Investment Story - simplywall.st
This Fund Bought $38 Million of Celcuity as Stock Surges on Investigational Cancer Drug Results - AOL.com
Celcuity (CELC): Assessing Valuation Following Recent Share Price Surge - Yahoo Finance
Celcuity: From Speculative Bet To Pre-Commercial Powerhouse (NASDAQ:CELC) - Seeking Alpha
Aug Intraday: Does Celcuity Inc. stock trade at a discount to peersPortfolio Gains Summary & Free Low Drawdown Momentum Trade Ideas - moha.gov.vn
(CELC) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
How Celcuity Inc. stock reacts to job market dataJuly 2025 Macro Moves & Free Community Consensus Stock Picks - BỘ NỘI VỤ
Celcuity to Present Updated Data from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium - The Manila Times
Celcuity To Present at Upcoming 8th Annual Evercore Healthcare Conference - The Manila Times
Celcuity Inc. to Participate in 8th Annual Evercore Healthcare Conference with CEO Fireside Chat Scheduled for December 3, 2025 - Quiver Quantitative
Celcuity to Present Updated Data from the PIK3CA Wild-Type - GlobeNewswire
Celcuity Inc. (CELC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Jefferies reiterates Buy rating on Celcuity stock ahead of cancer data - Investing.com Nigeria
Jefferies reiterates Buy rating on Celcuity stock ahead of cancer data By Investing.com - Investing.com South Africa
Celcuity (CELC)’s Clinical Success and M&A Potential Underpin Wolfe Research’s Bullish View - MSN
Celcuity (NASDAQ:CELC) Sets New 52-Week HighHere's What Happened - MarketBeat
Celcuity (CELC): Exploring Valuation as FDA Reviews Gedatolisib Application Under Expedited Program - Sahm
What analysts say about Celcuity Inc stockMarket Sentiment Indicators & Learn to Trade Without Fear of Loss - earlytimes.in
Celcuity (CELC)'s Clinical Success and M&A Potential Underpin Wolfe Research's Bullish View - Finviz
Finanzdaten der Celcuity Inc-Aktie (CELC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):